Chances and challenges of a long-term data repository in multiple sclerosis: 20th birthday of the German MS registry

Author:

Ohle Lisa-Marie,Ellenberger DavidORCID,Flachenecker Peter,Friede Tim,Haas Judith,Hellwig Kerstin,Parciak Tina,Warnke ClemensORCID,Paul Friedemann,Zettl Uwe K.,Stahmann AlexanderORCID

Abstract

AbstractIn 2001, the German Multiple Sclerosis Society, facing lack of data, founded the German MS Registry (GMSR) as a long-term data repository for MS healthcare research. By the establishment of a network of participating neurological centres of different healthcare sectors across Germany, GMSR provides observational real-world data on long-term disease progression, sociodemographic factors, treatment and the healthcare status of people with MS. This paper aims to illustrate the framework of the GMSR. Structure, design and data quality processes as well as collaborations of the GMSR are presented. The registry’s dataset, status and results are discussed. As of 08 January 2021, 187 centres from different healthcare sectors participate in the GMSR. Following its infrastructure and dataset specification upgrades in 2014, more than 196,000 visits have been recorded relating to more than 33,000 persons with MS (PwMS). The GMSR enables monitoring of PwMS in Germany, supports scientific research projects, and collaborates with national and international MS data repositories and initiatives. With its recent pharmacovigilance extension, it aligns with EMA recommendations and helps to ensure early detection of therapy-related safety signals.

Publisher

Springer Science and Business Media LLC

Subject

Multidisciplinary

Reference43 articles.

1. Flachenecker, P. & Stuke, K. National MS registries. J. Neurol. 255, 102–108 (2008).

2. Holstiege, J., Steffen, A., Goffrier, B. & Bätzing, J. Epidemiology of multiple sclerosis—A population-based, Germany-wide study. Versorgungsatlas 17(09), 1–16 (2017).

3. Committee for Medicinal Products for Human Use (CHMP). Guideline on Clinical Investigation of Medicinal Products for the Treatment of Multiple Sclerosis. https://www.ema.europa.eu/en/documents/scientific-guideline/guideline-clinical-investigation-medicinal-products-treatment-multiple-sclerosis_en-0.pdf (2015).

4. Flachenecker, P. et al. Multiple sclerosis registries in Europe—Results of a systematic survey. Mult. Scler. 20, 1523–1532 (2014).

5. Jalusic, K. O. et al. Effect of applying inclusion and exclusion criteria of phase III clinical trials to multiple sclerosis patients in routine clinical care. Mult. Scler. https://doi.org/10.1177/1352458520985118 (2021).

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3